Płatek A, Szymańska J. The impact of fasting on cardiovascular risk control in patients with metabolic dysfunction-associated steatotic liver disease. Gastroenterology Review/Przegląd Gastroenterologiczny. 2024;19(3):290-295. doi:10.5114/pg.2023.131394.
APA
Płatek, A., & Szymańska, J. (2024). The impact of fasting on cardiovascular risk control in patients with metabolic dysfunction-associated steatotic liver disease. Gastroenterology Review/Przegląd Gastroenterologiczny, 19(3), 290-295. https://doi.org/10.5114/pg.2023.131394
Chicago
Płatek, Anna E., and Julia A. Szymańska. 2024. "The impact of fasting on cardiovascular risk control in patients with metabolic dysfunction-associated steatotic liver disease". Gastroenterology Review/Przegląd Gastroenterologiczny 19 (3): 290-295. doi:10.5114/pg.2023.131394.
Harvard
Płatek, A., and Szymańska, J. (2024). The impact of fasting on cardiovascular risk control in patients with metabolic dysfunction-associated steatotic liver disease. Gastroenterology Review/Przegląd Gastroenterologiczny, 19(3), pp.290-295. https://doi.org/10.5114/pg.2023.131394
MLA
Płatek, Anna E. et al. "The impact of fasting on cardiovascular risk control in patients with metabolic dysfunction-associated steatotic liver disease." Gastroenterology Review/Przegląd Gastroenterologiczny, vol. 19, no. 3, 2024, pp. 290-295. doi:10.5114/pg.2023.131394.
Vancouver
Płatek A, Szymańska J. The impact of fasting on cardiovascular risk control in patients with metabolic dysfunction-associated steatotic liver disease. Gastroenterology Review/Przegląd Gastroenterologiczny. 2024;19(3):290-295. doi:10.5114/pg.2023.131394.
